NCT03479632

Brief Summary

By doing this study, researchers hope to learn the effects of aerobic exercise on heart, lung, and bone health in people who cannot walk after a stroke.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2018

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

March 19, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 27, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2020

Completed
Last Updated

March 8, 2019

Status Verified

March 1, 2019

Enrollment Period

1.8 years

First QC Date

March 19, 2018

Last Update Submit

March 7, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Resting Heart Rate

    Change from Baseline to Week 8

Secondary Outcomes (3)

  • Resting blood pressure

    Change from Baseline to Week 8

  • Change in vital capacity (VC)

    Change from Baseline to Week 8

  • Change in forced vital capacity (FVC)

    Change from Baseline to Week 8

Study Arms (2)

Intervention Group

EXPERIMENTAL

The intervention group will undergo an aerobic walking program using a treadmill, a body-weight support system, and an assistive device.

Behavioral: Aerobic walking program

Control Group

ACTIVE COMPARATOR

The control group will receive standard physical therapy (PT).

Behavioral: Standard physical therapy

Interventions

Participants will make 24 visits over an 8 week period, having 3 sessions per week. Each session will last about one hour.

Intervention Group

Participants will receive standard care they normally would after a stroke.

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Independent ambulation before stroke
  • Be able to understand and follow verbal commands in English
  • Have physicians' approval for exercise, and be in stable medical condition
  • Participant's first stroke
  • Unable to walk independently according to Functional Ambulation Category (FAC) (\<2) after in-patient rehabilitation treatment
  • Between 6 weeks to 5 years after stroke onset

You may not qualify if:

  • Current cardiovascular abnormalities other than stroke such as ischemic cardiovascular event or coronary artery bypass surgery less than 3 months ago
  • Musculoskeletal disorder which prevents subjects from participating in the exercise
  • Resting blood pressure more than 200/110 mm Hg
  • Current or previous pulmonary diseases in the past two years
  • Osteoporosis and restricted passive movement in the major joints of the lower limbs
  • Subjects will be excluded if they are unable to speak or understand English and/or unable to travel to the University of Kansas Medical Center (KUMC) Neuromuscular Research Laboratory

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Wen Liu

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abdulfattah Alqahtani

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2018

First Posted

March 27, 2018

Study Start

March 5, 2018

Primary Completion

December 5, 2019

Study Completion

March 5, 2020

Last Updated

March 8, 2019

Record last verified: 2019-03

Locations